DFCM
OPRX icon

Dark Forest Capital Management’s OptimizeRx OPRX Stock Holding History

Dark Forest Capital Management’s Portfolio OPRX Stock Details OPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-373
Closed -$6K – 1397
2022
Q3 		$6K Buy
+373
New +$7.37K ﹤0.01% 856
2022
Q2 		– Sell
-62
Closed -$2K – 1234
2022
Q1 		$2K Buy
+62
New +$2.74K ﹤0.01% 1168
2021
Q3 		– Sell
-11
Closed -$1K – 1470
2021
Q2 		$1K Buy
+11
New +$560 ﹤0.01% 785

Other funds holding OPRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
GIPM
G2 Investment Partners Management New York $549M AUM 179.59% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AC
Avenir Corporation Alexandria, Virginia $821M AUM 4.23% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dark Forest Capital Management's OPRX Position: Q4 2022 in Review

Dark Forest Capital Management sold out of OptimizeRx (OPRX) in Q4 2022, closing a stake of 373 shares — an estimated $6K sold.

Dark Forest Capital Management first reported a position in OPRX in Q2 2021 and held it in 3 quarters. The position peaked at $6K in Q3 2022. 128 funds tracked by Wall St. Rank hold OPRX as of Q4 2022.

  • Dark Forest Capital Management reported no remaining OptimizeRx position as of Q4 2022 after selling out during the quarter.
  • Dark Forest Capital Management sold 373 OptimizeRx shares in Q4 2022, an estimated $6K.
  • Dark Forest Capital Management first reported a position in OptimizeRx in Q2 2021 and held it in 3 quarters.
  • Dark Forest Capital Management's OptimizeRx position peaked at $6K in Q3 2022.
  • 128 funds tracked by Wall St. Rank held OptimizeRx as of Q4 2022.

Based on Dark Forest Capital Management's 13F filing for Q4 2022, filed 13 Feb 2023.